Global Certificate in Drug Regulation in the AI Era
-- ViewingNowThe Global Certificate in Drug Regulation in the AI Era is a timely and crucial course for professionals seeking to stay ahead in the rapidly evolving pharmaceutical industry. This certificate program focuses on the integration of Artificial Intelligence (AI) in drug development and regulation, addressing the latest trends and challenges in this field.
3,630+
Students enrolled
GBP £ 140
GBP £ 202
Save 44% with our special offer
ě´ ęłźě ě ëí´
100% ě¨ëźě¸
ě´ëěë íěľ
ęłľě ę°ëĽí ě¸ěŚě
LinkedIn íëĄíě ěśę°
ěëŁęšě§ 2ę°ě
죟 2-3ěę°
ě¸ě ë ěě
ë기 ę¸°ę° ěě
ęłźě ě¸ëśěŹí
⢠Global Drug Regulation Overview: Understanding the international landscape of drug regulation, including the role of organizations such as the FDA, EMA, and WHO.
⢠Artificial Intelligence (AI) in Drug Development: Exploring the use of AI in drug discovery, design, and development, including machine learning and deep learning technologies.
⢠AI Ethics and Regulation: Examining ethical considerations and regulatory challenges in the use of AI in drug development, including data privacy and bias.
⢠AI Tools for Drug Regulation: Investigating the use of AI in drug regulation, including real-world evidence, post-market surveillance, and pharmacovigilance.
⢠Clinical Trials and AI: Evaluating the role of AI in clinical trials, including trial design, patient recruitment, and data analysis.
⢠AI in Drug Approval and Authorization: Exploring the use of AI in drug approval and authorization processes, including the evaluation of efficacy and safety data.
⢠AI in Drug Manufacturing and Supply Chain: Investigating the use of AI in drug manufacturing and supply chain management, including quality control, traceability, and risk management.
⢠Cybersecurity and AI in Drug Regulation: Examining the cybersecurity challenges and risks associated with the use of AI in drug regulation, including data protection and cyberattacks.
⢠Future of AI in Drug Regulation: Evaluating the future potential of AI in drug regulation, including opportunities for innovation, collaboration, and growth.
ę˛˝ë Ľ 경ëĄ
ě í ěęą´
- 죟ě ě ëí 기본 ě´í´
- ěě´ ě¸ě´ ëĽěë
- ěť´í¨í° ë° ě¸í°ëˇ ě ꡟ
- 기본 ěť´í¨í° 기ě
- ęłźě ěëŁě ëí íě
ěŹě ęłľě ěę˛Šě´ íěíě§ ěěľëë¤. ě ꡟěąě ěí´ ě¤ęłë ęłźě .
ęłźě ěí
ě´ ęłźě ě ę˛˝ë Ľ ę°ë°ě ěí ě¤ěŠě ě¸ ě§ěęłź 기ě ě ě ęłľíŠëë¤. ꡸ę˛ě:
- ě¸ě ë°ě 기ę´ě ěí´ ě¸ěŚëě§ ěě
- ęśíě´ ěë 기ę´ě ěí´ ęˇě ëě§ ěě
- ęłľě ě겊ě ëł´ěě
ęłźě ě ěąęłľě ěźëĄ ěëŁí늴 ěëŁ ě¸ěŚě뼟 ë°ę˛ ëŠëë¤.
ě ěŹëë¤ě´ ę˛˝ë Ľě ěí´ ě°ëŚŹëĽź ě ííëę°
댏롰 ëĄëŠ ě¤...
ě죟 돝ë ě§ëʏ
ě˝ě¤ ěę°ëŁ
- 죟 3-4ěę°
- 쥰기 ě¸ěŚě ë°°ěĄ
- ę°ë°Ší ëąëĄ - ě¸ě ë ě§ ěě
- 죟 2-3ěę°
- ě 기 ě¸ěŚě ë°°ěĄ
- ę°ë°Ší ëąëĄ - ě¸ě ë ě§ ěě
- ě 체 ě˝ě¤ ě ꡟ
- ëě§í¸ ě¸ěŚě
- ě˝ě¤ ěëŁ
ęłźě ě ëł´ ë°ę¸°
íěŹëĄ ě§ëś
ě´ ęłźě ě ëšěŠě ě§ëśí기 ěí´ íěŹëĽź ěí ě˛ęľŹě뼟 ěě˛íě¸ě.
ě˛ęľŹěëĄ ę˛°ě ę˛˝ë Ľ ě¸ěŚě íë